Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-11-21
1997-01-28
Naff, David M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
424 9464, 514802, A61K 3848, A61K 3800
Patent
active
055978002
ABSTRACT:
A treatment of ischemia and the attendant reperfusion injury entails the administration plasmin and plasmin-forming proteins, including lys-plasminogen and similar substances. Lys-plasminogen, which can be obtained from the proteolytic cleavage of glu-plasminogen, has been found to have a protective effect on tissue that has been injured by ischemic conditions. The administration of lys-plasminogen alone, in a dosage of about 10-1000 caseinolytic units/kg, can be used to treat subjects during the time of reperfusion and after reperfusion has already occurred. Lys-plasminogen also can be administered in conjunction with clot lysis therapies, such as those that employ tissue plasminogen activator and the like. Lys-plasminogen can also lessen cerebral edema which results from cerebral ischemia.
REFERENCES:
patent: 4808405 (1989-02-01), Smith et al.
patent: 4996050 (1991-02-01), Tsukada et al.
patent: 5084274 (1992-01-01), Griffin et al.
patent: 5256642 (1993-10-01), Fearon et al.
Fredenburgh et al., J. of Bio. Chem., vol. 207:26150-26156 (Dec. 1992).
Shih et al., P.S.F.B.M. vol. 202:258-264 (1993).
Nieuwenhuizen et al., Eur. J. Biochem., vol. 174:163-169 (1988).
Saragovi et al., Science, vol. 253:792-795 (Aug. 1991).
Schalij et al., Neth. J. Med., 40:69-75 (Feb. 1992).
Pacouret et al., Arch. Mal. Coeur Vaiss, 83:25-29 (Feb. 1990).
Juhan et al., Bull Acad. Natl. Med., 174:197-207 (Feb. 1990).
Giraud et al., J Mal Vasc, 10:321-326 (1985).
Kerrigan et al., Microsurgery, vol. 14:165-175 (1993).
Werner et al., Stroke, vol. 22:910-914 (Jul. 1991).
Braunwald et al., J. Clin. Invest., vol. 76:1713-1719 (Nov. 1985).
Wauquier et al., Neuropharmacology, vol. 28:837-846 (1989).
Oh et al., Stroke, vol. 22:915-921 (Jul. 1991).
Eibl Johann
Pichler Ludwig
Schwarz Hans-Peter
Immuno Aktiengesellschaft
Naff David M.
Saucier S.
LandOfFree
Treatment with lys-plasminogen of reperfusion injury and brain e does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment with lys-plasminogen of reperfusion injury and brain e, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment with lys-plasminogen of reperfusion injury and brain e will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-941511